Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Can Hikma's Branded Momentum Sustain Its Healthier Margin Mix? (LSE:HIK)

Hikma Pharmaceuticals plc (LSE:HIK) shares rose 0.18% to 1,653p on 13 November 2026. The pharmaceutical group remained in focus after publishing interim results for the six months ended 30 June 2026 on 6 August 2026.

Divya Sood | 13 November 2026

Can Spire Healthcare's Self-Pay and Primary Care Growth Support Its Next Chapter? (LSE:SPI)

Spire Healthcare Group plc (LSE:SPI) shares rose 0.20% to 248p on 13 November 2026. The UK private hospital group remained in focus after publishing interim results for the six months ended 30 June 2026 on 30 September 2026.

Divya Sood | 13 November 2026

Specialty Medicines Lead the Way: GSK (LSE:GSK) Reaffirms Its 2026 Plan After Third Quarter

GSK Plc (LSE:GSK) shares edged higher by 0.08% to around 1,902.5p today, following third-quarter results on 28 October 2026 in which the pharmaceutical group reaffirmed its full-year guidance.

Ankur Sharma | 13 November 2026

Everyday Health Brands in Focus: Haleon (LSE:HLN) Highlights Oral Health Momentum

Haleon Plc (LSE:HLN) shares edged higher by 0.09% to around 341.5p today, following its third-quarter trading statement on 29 October 2026, which reported organicRevenuegrowth of 2.6%.

Ankur Sharma | 13 November 2026

Infusion Care and Continence Innovation: What Drives Convatec (LSE:CTEC) Into the Second Half

Convatec Group Plc (LSE:CTEC) shares edged higher by 0.16% to around 256.2p today, as investors follow the group's progress towards faster growth in the second half of 2026.

Ankur Sharma | 13 November 2026

Oncology Momentum and a Deep Pipeline: Reading AstraZeneca (LSE:AZN) Today

AstraZeneca Plc (LSE:AZN) shares edged higher by 0.06% to around 13,938.0p today. The move follows third-quarter results showing totalRevenuegrowth of 7% and the reconfirmation of full-year guidance.

Ankur Sharma | 13 November 2026

Can Australia Give CVS Group's Vet Network a New Growth Chapter? (LSE:CVSG)

CVS Group plc (LSE:CVSG) shares rose 1.14% to 1,425p on 13 November 2026. The veterinary services provider remains in focus after its final results for the year ended 30 June 2026, published on 24 September 2026.

Divya Sood | 13 November 2026

Scancell Holdings (LSE:SCLP): Small-Cap Growth-Oriented Healthcare Stock in Focus as Investors Track the Next Catalyst

• The immediate focus on 12 November 2026 is linked to the company's latest operating, strategic, financial or project developments.

Ankur Sharma | 13 November 2026

Optima Health (LSE:OPT): Growth-Oriented Small-Cap Story Draws Fresh Attention Ahead of the Next Update

• The immediate focus on 12 November 2026 is linked to the company's latest operating, strategic, financial or project developments.

Ankur Sharma | 13 November 2026

Tristel (LSE:TSTL): Why This Small-Cap Healthcare Stock Is Back on the Market Radar

• The immediate focus on 12 November 2026 is linked to the company's latest operating, strategic, financial or project developments.

Ankur Sharma | 13 November 2026
Support

Hi! How can we help you today?

Loading…